Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization–embryo transfer (Q44442541)

3 December 2017

Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer (English)

1 reference

3 December 2017

Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization–embryo transfer (English)

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04928-2

2 January 2024

1

Ariel Weissman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749425

2 January 2024

author name string

Jacob Farhi

2

1 reference

3 December 2017

Moshe Royburt

3

1 reference

3 December 2017

Hana Nahum

4

1 reference

3 December 2017

Marek Glezerman

5

1 reference

3 December 2017

David Levran

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

full work available at URL

3 December 2017

http://www.fertstert.org/article/S0015028202049282/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749425

https://api.elsevier.com/content/article/PII:S0015028202049282?httpAccept=text/xml

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04928-2

https://api.elsevier.com/content/article/PII:S0015028202049282?httpAccept=text/plain

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(02)04928-2

2 January 2024

published in

Fertility and Sterility

1 reference

3 December 2017

79

1 reference

3 December 2017

4

1 reference

3 December 2017

886-892

1 reference

Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Zygote intrafallopian transfer may improve pregnancy rate in patients with repeated failure of implantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

The sequential use of a luteinizing hormone-releasing hormone (LH-RH) agonist and human menopausal gonadotropins to stimulate folliculogenesis in patients with resistant ovaries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Utilization of GnRH agonists for poor responders in an IVF programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Treatment of low responders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Impact of leuprolide acetate on the response to follicular stimulation for in vitro fertilization in patients with normal basal gonadotropin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Effectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Roles of follicle stimulating hormone and luteinizing hormone in controlled ovarian hyperstimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Gonadotropin suppression with oral contraceptives before in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Ovarian activity during follicular-phase down regulation in in vitro fertilization is associated with advanced maternal age and a high recurrence rate in subsequent cycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Progestogen therapy and prevention of functional ovarian cysts during pituitary desensitisation with GnRH agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: a prospective, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

Reducing the Risk of Multiple Births by Transfer of Two Embryos after in Vitro Fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904928-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

1 reference

3 December 2017

1 reference